» Articles » PMID: 39343912

In Regard to Castagnola Et Al. (doi: 10.1186/s12903-023-03050-7)

Overview
Journal BMC Oral Health
Publisher Biomed Central
Specialty Dentistry
Date 2024 Sep 29
PMID 39343912
Authors
Affiliations
Soon will be listed here.
Abstract

We are grateful to the authors of the study by Castagnola et al., which sought to ascertain the prevalence of tooth necrosis in patients undergoing mandibulotomy or mandibulectomy for head and neck cancer. In order to prevent surgical problems, the researchers suggested doing root canal therapy on the teeth next to the surgical site prior to surgery. Although the results offer insightful information about tooth necrosis in patients with head and neck cancer who have had mandibulotomies or mandibulectomy, we would like to voice our concerns about the reported data in order to give a stronger basis for future studies in this field.

Citing Articles

TIMP4 serves as a novel potential prognostic biomarker for oral squamous cell carcinoma.

Zhou L, Tang C, Shuai R, Chen B, Yang X, He Y Sci Rep. 2025; 15(1):6313.

PMID: 39984587 PMC: 11845745. DOI: 10.1038/s41598-025-90237-3.

References
1.
Nabil S, Nazimi A, Nordin R, Hariri F, Mohamad Yunus M, Zulkiflee A . Mandibulotomy: an analysis of its morbidities. Int J Oral Maxillofac Surg. 2019; 47(12):1511-1518. DOI: 10.1016/j.ijom.2018.05.020. View

2.
Dimitrievich G, GRIEM M . Radiosensitivity of vascular tissue. I. Differential radiosensitivity of capillaries: a quantitative in vivo study. Radiat Res. 1984; 99(3):511-35. View

3.
Topkan E, Kucuk A, Somay E, Yilmaz B, Pehlivan B, Selek U . Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors. J Clin Med. 2023; 12(8). PMC: 10143049. DOI: 10.3390/jcm12083025. View

4.
Bras J, de Jonge H, van Merkesteyn J . Osteoradionecrosis of the mandible: pathogenesis. Am J Otolaryngol. 1990; 11(4):244-50. DOI: 10.1016/0196-0709(90)90084-9. View

5.
Yilmaz B, Somay E, Topkan E, Pehlivan B, Selek U . Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients. Eur Arch Otorhinolaryngol. 2023; 280(5):2575-2584. DOI: 10.1007/s00405-023-07864-7. View